SLPI exhibited a decreasing trend, although the difference was not statistically significant (Fig. 6 ).
← all excerpts
Bioactive secretory leukocyte protease inhibitor (SLPI)-derived short peptides (SDSPs) attenuate LPS-induced inflammatory responses in macrophages.
1
—
—